Zobrazeno 1 - 7
of 7
pro vyhledávání: '"V. R. Sørensen"'
Publikováno v:
Diabetologia. 50:922-929
We investigated the survival rate of Danish diabetic patients with end-stage renal disease (ESRD) between 1990 and 2005 and evaluated possible predictors of survival rate.Data were obtained from the Danish National Register on Dialysis and Transplant
Publikováno v:
Kidney International. 70:187-191
Despite an improvement in diabetes care during the last 20 years, the number of diabetic patients starting renal replacement therapy (RRT) has continued to increase in the Western world. The aim was to study the incidence of patients starting RRT in
Autor:
M. V. N. Andersen, Torquil Watt, Elisabeth R. Mathiesen, Jakob Bue Bjorner, Bo Feldt-Rasmussen, V. R. Sørensen
Publikováno v:
Diabetologia. 50(11)
The aim of this study was to describe the prevalence of complications, health-related quality of life (HRQOL) and the influence of beliefs about control over health in diabetic dialysis patients.Of 53 eligible diabetic patients on chronic dialysis du
Publikováno v:
Sørensen, V R, Mathiassen, E R, Clausen, P, Flyvbjerg, A & Feldt-Rasmussen, B 2005, ' Impaired vascular function during short-term poor glycaemic control in Type 1 diabetic patients ', Diabetic. Med., vol. 22, pp. 871-876 .
Aim To study the effects of short-term poor glycaemic control on vascular function in Type 1 diabetic patients. Methods Ten Type 1 diabetic patients, with diabetes duration of less than 10 years and normal urinary albumin excretion and ophthalmoscopy
Autor:
Inger Marie Jensen Hansen, T. Laursen, V. R. Sørensen, Hanne Merete Lindegaard, Tove Lorenzen, Jolanta Grydehøj, René dePont Christensen, Jens-Erik Beck Jensen, Oliver Hendricks, E. Næser, N. Dufour, Mette Yde Dam, S. Butt, Tanja Schjødt Jørgensen, L. Zanjani, Marlene Andersen, Jakob Espesen, Niels Steen Krogh, Anita Kincses, L. Larsen, Barbara Unger, Henning Bliddal, Mette Østergaard, S. Vildhøj, M. Hansen, L.E. Kristensen, Merete Lund Hetland, Johnny Lillelund Raun, Prabhat Kumar, D V Jensen
Publikováno v:
Annals of the Rheumatic Diseases. 73:613.2-614
Background Concurrent use of methotrexate (MTX) and a biologic is generally the standard-of-care in patients with RA who have disease activity despite MTX. It has been estimated that between 10 and 30% of RA patients are MTX-intolerant (1). For patie
Publikováno v:
Zeitschrift für Gastroenterologie. 39:29-29
Publikováno v:
Zeitschrift für Gastroenterologie. 39:42-42